Biotechnology and Bioprocess Engineering:BBE

The Korean Society for Biotechnology and Bioengineering (한국생물공학회)
권호 표지

Low Density Lipoprotein(LDL), Atherosclerosis and Antioxidants

  • Ryu, Beung-Ho (Department of Food Science and Biotechnology, Kyungsung University)
  • Published : 2000.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

A crucial and causative role in the pathogenesis of atherosclerosis is believed to be the oxidative modification of low density lipoprotein (LDL). The oxidation of LDL involves released free radical driven lipid peroxidation. Several lines of evidence support the role of oxidized LDL in atherogenesis. Epidemiologic studies have demonstrated an association between an increased intake of dietary antioxidant vitamins, such as vitamin E and vitamin C and reduced morbidity and mortality from coronary artery diseases. It is thus hypothesized that dietary antioxidants may help prevent the development and progression of atherosclerosis. The oxidation of LDL has been shown to be reduced by antioxidants, and, in animal models, improved antioxidants may offer possibilities for the prevention of atherosclerosis. The results of several on going long randomized intervention trials will provide valuahle information on the efficacy and safety of improved antioxidants in the prevention of atherosclerosis. This review a evaluates current literature involving antioxidants and vascular disease, with a particular focus on the potential mechanisms.

Keywords

References

  1. J. Clin. Invest v.34 The distribution and chemical composition of ultracentrifuglly separated lipoproteins in human serum R. J. Havel;H. A. Eder;J. H. Bragdon
  2. Free Radic. Biol. Med v.9 Role of oxidatively modified LDL in atherosclerosis Stenbrecher;U. P.;H. Zhang;M. Lougheed
  3. N. Engl. J. Med v.320 Beyond cholesterol;Modeficarions of low density lipoprotein that increases its atherogenicity Steinverg, D.;S. Parthasarathy;T. E. Carew;J. C. Khoo;J. L. Wiztum
  4. J. Clin. Invest v.88 Role of oxidized low density lipoprotein in atherobenesis Wiztum, J. L.;D. steinverg
  5. Free Radic. Bile. Med v.9 Role of oxidatively modified LDL in atherosclerosis Steinvrdcher, U. P.;H. Zhang;M. Lougheed
  6. Lancet v.339 Wine, alcohol, platelets, and the French Paradox for coronary heart disease Renaud, D.;M. De Lorgiril
  7. J. Clin. Invest v.84 Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man Yla-Hartuala, S.;W. Palinski;M, E. Rosenfeld;S. Parhasrathy;T. E. Carew;S. Butler;J. L. Wiztum;D. Steinberg
  8. Free Radic. Biol. Med v.13 The role of lipid peroxidation and antioxidants in oxidative modification of LDL Esterbauer, H.;J. Gebiki;H. Puhl;G. Jurgens
  9. J. Lipid Res v.33 The effec of dietary supplementation with alpha-tocopherol in the oxidative modification of LDL Jiaial, I.;S. M. Grundy
  10. Med. Hypotheses v.16 Fruit and vegetable consumption and cardiovascular disease mortality Verlangieri, A. J.;J. C. Kapeghian;S. el-Dean;M. Bush
  11. Ann. NY Acad. Sci. v.570 Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology Gey, K. F. ;P. Puska
  12. J. Hosp. Med v.94 Free radicals and antioxidant systems in health and disease Br Sinclair, A. J. ;A. H. barnett;J. Lunec
  13. Ann. Med v.23 Effect of antioxidants on oxidative modification of LDL Esterbauer, H.;H. Puhl;M. Cieber-Rotheneder;G. Waeg;H. Rabl
  14. Free Rad. Biol. Med. v.13 The role of lipid peroxidation and antioxidants in oxidative modification of LDL Esterbauer, H.;J. Gebicki;H. Puhl;G. Jurgens
  15. Curr Opin Lipidol v.2 Cytotoxidity of oxidized lipoproteins Chisolm G. M.
  16. J. Clin. Invest v.27 Culture of human endothelial cells derived from human umbilical rein Jaffe, D. A.;R. L. Nachman;C. G.;Becker;C. R. Minick
  17. Atherosclerosis v.11 Rabbit and human atherosclerotic lesions contain lgG that recognizes MDA-LDL and copper-oxidized LDL Yla-Hartuala, S.;W. Palinski;D. Steinverg;D. Steinverg;J. L. Wiztum
  18. Atherosclerosis v.8 Presence of a moditied low density lipoprotein in human Avogaro, P.;G. Bittolo-Bon;F. Cazzolato
  19. Scand.J. Clin. Lib. Invest v.39 Injury to human endothelial cells in culture induced by low density lopoproteins Henriksen T.;S. A. Evensen;B. Carlande
  20. Am. J. Clin. Nutr. v.53 Inverse corrdlation between plasma vitamin E and Mortality from ischemic heart desease in cross-cultyral epidemiology Gey, K. D.;P. Preska;P. Jordan;U. K. Moser
  21. Lancet v.337 Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene Rienersas, R. A.;D. A. Wood;C. C. A. Macintyre;R. A. Elton;K. F. Gey;M. F. Oliver
  22. J. Biol. Chem v.226 The influence of oxidatirely modified low density lipoproteins on expression of latelet-derived growth factor by human monocyte-derived macro phages Trevor-ME, L.;A. Chait;W. Raines;R. Ross
  23. J. Am. Coll. Nutr v.12 Effect on mortality and reinfarction of adding fruits and vegetables to a prudent diet in the Indian experiment of infact Survival Singh, R. B.;M. A. Niaz;S. Ghosh;S. S. Rastogi
  24. N. Engl. J. Med v.328 Vitamin E Consumption and the risk of coronary disease in women Stanpfer, M. J.;C. H. Hennekens;J. E. Manson;G. A. Colditz;B. Rosner;W. C. Willett
  25. N. Engl. J. Med v.328 Vitamin E consumption and the risk of coronary heart desease in men Rimm, E. B.;M. J. Stampfer;A. Ascherio;E. Giovannucci;G. A. Colditz;W. C. Willett
  26. Am. J. Clin. Nute. v.64 Vitamin E and vitmin C supplement use and risk of allcause and coronary beart desease mortality in older persons;The established populations for epidemiologic studies of the elderly Losonczy, K. G.;T. B. Haffis;R. J. Havlik
  27. Lancet v.347 Randomized controlled trial of vitamin E in patients with coronary disease;Cambridge heart antioxidant study(GHAO) Stephens, N. G.;A. Parsons;P. M. Schofield;F. Kelly;K. cheeseman;M. J. Mitecenson
  28. Curr. Opin. Lipidol v.3 Antioxidants and atherosclerosis Jialal. I;C. Scaccini
  29. Proc. Natl. Acad. Sci. USA v.89 probucol inhibits neointinal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit Ferns, G. A. A.;L. Forster;A. Stewart-Lee;Ml Konneh;J. Nourooz-Zadeh;E. E. Anggard
  30. J. Clin. Invest v.91 Antioxidant treatmentin inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits Freyschuss, A.;A. Stiko-Rahm;J. Swedenborg;P. Henriksson;I. Bjorkhem;L. Berglund;J. Nilsson
  31. Epidemiology v.3 Vitamin C intake and mortality among a sample of the United States population Enstrom, J. E.;L. E. Kanim;M. A. Klein
  32. Circulation v.84 A. PTCA;Pharnacological interventions to modify restenosis Lee, Y. J.;H. Yanaguchi;H. Daida;H. Yokoi;J. Miyano;J. Takaya;H. Sakurai;Noma
  33. Circulation v.88 Vitamics C and E improve the response to coronary balloon injury in the pig;Effect of vascular remodeling Nunes, G. L.;D. S. Sgoutas;S> R. Sibman;S. Sritt;M. B. Gravanis;King Ⅲ;B. C. Berk
  34. Atheroscler. Thromb v.14 Antiproliferative effect of desferrioxamine onvascular smooth muscle cells in vitro and in vivo Perreco, E;S. Ucchino;C. Di Febbo;N. Di Bartolomeo;D. Angelucci;A. M. Napolitano;A. Mezzetti;F. Cuccutullo
  35. J. Am. Coll. Cardiol v.19 Preventive effect on restenosis after PTCA by Ebselen;A newly synthesized anti-inflammatory agent Hirayama, A.;S. Nanto;T. Ohara;K. Nishida;Y. Okuyama;K. Kodama
  36. Kor. J. Appl. Microbiol. Biotechnol v.25 Antioxidant of silymarin low density lipoprotein on macrophages Lee, B. C.;B. H. Ryu
  37. Korean J. Life Sci v.8 Antioxidative effect of lilybin purified silybum marianum on modification of human low density lipoprotein Ryu, B. H. ;H. S. Kim;B. C. Lee;H. S. Lee